Status:
COMPLETED
Model of Predicting Biochemical Recurrence After Radical Prostate Cancer Based on Pre-treatment PSMA PET / MR Image Features
Lead Sponsor:
Ruijin Hospital
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Brief Summary
The purpose of this study is to investigate the predictive value of preoperative 18F-PSMA-1007 PET/MR in the predictive effect of biological recurrence (BCR) after radical prostatectomy (RP) for local...
Detailed Description
Construct a predictive model for biochemical recurrence (BCR) in patients after radical prostatectomy using imaging parameters from preoperative 18F-PSMA-1007 PET/MRI, and compare the predictive perfo...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Histologically confirmed prostate cancer without other types of malignancy -
Exclusion
- Surgery or endocrine therapy is performed prior to the examination
- \-
Key Trial Info
Start Date :
November 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2024
Estimated Enrollment :
203 Patients enrolled
Trial Details
Trial ID
NCT06604377
Start Date
November 1 2023
End Date
June 30 2024
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ruijin Hospital affiliated to Shanghai Jiao Tong University of Medicine
Shanghai, China